The second annual Tee Off for Testicular Cancer golf tournament in Norfolk raised nearly $40,000 in support of the Testicular Cancer Awareness Foundation. The event brought together survivors, families, and the local community to raise awareness, promote early detection, and support those impacted.
Read MoreDuring Testicular Cancer Awareness Month, NADS Organic Underwear partnered with Testicular Cancer Awareness Foundation, to bring the “Check Your Nads” March to the streets of Austin. The bold six-mile march turned heads and brought survivors, supporters, and advocates together to raise awareness and start conversations.
Read MoreThis episode highlights the importance of recognizing testicular cancer symptoms, advocating for your health, and understanding that survivorship is about more than just treatment—it’s about rebuilding physically, mentally, and spiritually.
Read MoreBeyond treatment, this episode explores the importance of being treated at high-volume centers, avoiding overtreatment, and understanding the long-term effects of both surgery and chemotherapy. Dr. Daneshmand also discusses the status and future of MicroRNA 371 biomarker testing.
Read MoreOsvaldo walks through the shock of hearing “you have cancer,” undergoing an orchiectomy, and waking up to learn that the his testicle had been completely removed. He candidly describes the emotional reality of losing a testicle, the confusion around what doctors were removing, and the relief of finally being free from the constant pain after surgery. His story is an important reminder that testicular cancer symptoms can include a lump, swelling, heaviness, and persistent back pain — and that early detection can save your life.
Read MoreAt the 2025 Testicular Cancer Conference, Dr. Lindsay Frazier discussed how international collaboration is accelerating research for testicular cancer and other germ cell tumors through the Malignant Germ Cell Tumor International Consortium (MaGIC).
Read MoreDr. Feldman began by reflecting on the history of testicular cancer treatment and the dramatic shift brought about by cisplatin-based chemotherapy. Key takeaways included:
Before cisplatin, metastatic testicular cancer was often fatal, with most patients not surviving
The introduction of cisplatin is considered one of the greatest medical advances of the 20th century
Survival rates for metastatic disease improved from roughly 20% to nearly 80%
While highly effective, cisplatin is associated with significant short- and long-term side effects, making toxicity reduction an ongoing priority
Whether you’re navigating a testicular cancer diagnosis, supporting someone going through treatment, or simply learning more about testicular cancer symptoms, recurrence, and survivorship, Greg’s story is a powerful reminder that early detection matters—and that strength often shows up in the determination to keep fighting, even when the battle returns.
Read MoreIn this episode of It Takes Balls, Eduardo Celis, a Venezuelan-American, shares his journey through testicular cancer at age 35, a diagnosis that can feel especially unexpected for men who consider themselves healthy and in their prime. Eduardo opens up about noticing changes after a vasectomy, navigating the uncertainty of symptoms, and ultimately hearing the words no one expects.
Read MoreDuring the 2026 ASCO Genitourinary Cancers Symposium, the Testicular Cancer Awareness Foundation hosted 55 physicians and researchers at Marianne’s speakeasy in San Francisco for a Meet & Greet Social sponsored by Fennec Pharmaceuticals.
Read MoreJustin underwent four rounds of VIP chemotherapy (cisplatin, etoposide, and ifosfamide), administered inpatient 24 hours a day for a week at a time. He openly discusses the brutal side effects of chemo, including severe pain, tinnitus from cisplatin, dangerously low platelet counts, and the emotional toll of living in the oncology ward. After chemo reduced the tumor to a dead mass, he endured an 8.5-hour open chest surgery, losing two-thirds of his right lung, part of his heart wall, and major veins that had to be reconstructed.
Read MoreDr. Feldman began by reflecting on the history of testicular cancer treatment and the dramatic shift brought about by cisplatin-based chemotherapy. Key takeaways included:
Before cisplatin, metastatic testicular cancer was often fatal, with most patients not surviving
The introduction of cisplatin is considered one of the greatest medical advances of the 20th century
Survival rates for metastatic disease improved from roughly 20% to nearly 80%
While highly effective, cisplatin is associated with significant short- and long-term side effects, making toxicity reduction an ongoing priority
